Blockchain Registration Transaction Record
NanoViricides, Inc. Updates Antiviral Pipeline with Potential Breakthrough Treatment for Measles and MPox
NanoViricides, Inc. provides a strategic update on its antiviral pipeline with NV-387 as a potential breakthrough treatment for Measles and MPox. The company aims to fill critical gaps in global antiviral preparedness by developing treatments for these diseases amid rising case counts and vaccine failures.

This news matters as NanoViricides aims to address critical gaps in global antiviral preparedness by developing NV-387 as a treatment for Measles and MPox. With rising global case counts and vaccine failures, the company's strategic update provides hope for effective antiviral solutions in the fight against these diseases.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x3f12ebb507666c8d3d4dab7ebab326a5c77820dd99d8b3ccbf0697f8061c12ff |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | harpSSa7-66426313bfe5d310a6fa79c359071760 |